Monitoring of Specific Birth Defects Associated With Exposure to Lamotrigine in Pregnancy Through the EUROCAT Network.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2014
At a glance
- Drugs Lamotrigine (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Acronyms EUROCAT
- Sponsors GlaxoSmithKline
- 29 Sep 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 31 Aug 2012 Planned number of patients (1) added as reported by ClinicalTrials.gov record.
- 03 Feb 2010 New trial record